Cancer News

Experimental Immunotherapy Galinpepimut-S May Benefit Multiple Myeloma Patients

Posted on
Health Medical Breakthroughs Treatment

(Myeloma Research News) According to a recent article published Myeloma Research News, patients with high-risk multiple myeloma may benefit from an experimental immunotherapy from SELLAS Life Sciences called galinpepimut-S, following an autologous stem cell transplant (ASCT). The data was gathered from a Phase 2 clinical trial which shows that the agent nearly doubles the progression-free survival rates […]